MAM
Johnson & Johnson expands ‘India Detects to Defeat’ lung cancer campaign
Phase II rolls out multilingual illustrated booklet to boost early detection.
MUMBAI: Johnson & Johnson just turned lung cancer awareness into a comic-book plot twist because sometimes the best way to catch a villain early is to tell its story before it strikes. Johnson & Johnson India has launched Phase II of its nationwide disease awareness initiative ‘India Detects to Defeat’ on the occasion of World Lung Cancer Day, aiming to drive early detection and timely intervention for better outcomes in lung cancer care, with special focus on underserved populations.
Building on Phase I’s collaboration with Amar Chitra Katha which reached over 786 million people and around 6,500 healthcare providers, the new phase expands a specially designed illustrated booklet into five regional languages: Hindi, Kannada, Tamil, Malayalam and Telugu. Available in both print and digital formats via QR codes, the booklet will be distributed through select healthcare provider clinics nationwide.
The urgency is underscored by stark statistics, lung cancer incidence in India is projected to rise from 63,708 cases in 2015 to 81,219 by 2025, driven by smoking (nearly 100 million adult smokers) and environmental pollution. It remains the fourth most common cancer in India, with around 81,000 new cases and 75,000 deaths annually. Five-year survival rates hover between 3.7 per cent and 17 per cent, largely due to late-stage diagnosis, while 85–90 per cent of cases are non-small cell lung cancer (NSCLC). An estimated 25–30 per cent of patients harbour EGFR mutations, highlighting the need for comprehensive molecular testing at diagnosis.
Johnson & Johnson India general manager & South Asia operations Pushkar Kulkarni said, “Lung cancer continues to be diagnosed late, limiting timely, life-saving intervention making early detection our most powerful tool. Through Phase 1 we reached over 786 million people and ~6,500 healthcare providers. In 2026 we are strengthening this commitment by translating our booklet into regional languages to help families across India recognise early signs and take timely action.”
Tinkle (Amar Chitra Katha Pvt Ltd) editor-in-chief Gayathri Chandrasekhar added, “Through these relatable stories, we aim to ignite crucial conversations around lung health and early detection, ultimately empowering families to make informed, life-saving health decisions.”
Sir H.N. Reliance Foundation Hospital director of medical & precision oncology Sewanti Limaye noted, “The ability to detect lung cancer early is, quite simply, the most powerful tool we have against this formidable disease. By empowering individuals with clear, actionable information we fundamentally shift the paradigm from late-stage diagnosis to potentially curable outcomes.”
In a country racing against rising cancer numbers, J&J isn’t just raising awareness, it’s handing out storybooks that could literally save lives, proving that sometimes the best medicine starts with turning a statistic into a story everyone understands.
